Delivery Order SPE2DE24D0013-SPE2D625F9VZ7
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- The Defense Department's Medical Supply Chain division awarded Cepheid Inc. a $17,952 firm fixed-price delivery order on August 4, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract is set to be completed by August 18, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of the Defense Department's reliance on Cepheid's GeneXpert...
- Cepheid has been awarded a delivery order valued at $7,276 under contract number 4568920470 for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. This firm fixed-price delivery order, issued by the Medical Supply Chain division of the Department of Defense, will be performed in Sunnyvale, California, with an ultimate completion date of August 11, 2025. The contract carries no set-aside designation and represents a continuation of...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $3,400 firm fixed-price delivery order on July 28, 2025, for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) diagnostic testing supplies. The delivery order, contract number 4568910321, is set to be completed by August 4, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract is funded by the Defense Department's Medical Supply Chain entity and utilizes no...
- The U.S. Defense Department's Medical Supply Chain division awarded a $23,475.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPCOV2/FLU/RSV-10, was awarded on July 29, 2025, with an ultimate completion date of August 12, 2025, and carries no set-aside designation. Work will be performed at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- The U.S. Department of Defense Medical Supply Chain awarded a $5,440 delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for COVID-19, influenza, and respiratory syncytial virus (RSV) testing solutions. This firm fixed-price delivery order, issued on July 23, 2025, with an ultimate completion date of July 30, 2025, carries no set-aside designation and represents performance work in Sunnyvale, California. The delivery order is associated with...
- The U.S. Department of Defense awarded a $2,040 firm fixed-price delivery order to Cepheid Inc. on August 5, 2025, under contract number 4569009257 for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus testing. The contract, which carries no set-aside designation, is set to conclude by August 12, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order falls under one of Cepheid's two significant...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- The Defense Logistics Agency's Medical Supply Chain division awarded an $6.8K firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer specializing in infectious disease testing solutions. This delivery order, issued on August 5, 2025, with an ultimate completion date of August 12, 2025, is designated as XPCOV2/FLU/RSV-10 and relates to diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV). The...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F9VZ7Delivery Order
The Defense Logistics Agency awarded a $2,992 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, under contract 4568960202 for COVID-19, influenza, and respiratory syncytial virus (RSV) testing supplies and services. This firm fixed-price delivery order, with no set-aside designation, is scheduled for completion by August 15, 2025, and represents procurement of diagnostic reagents and related testing materials from Cepheid's GeneXpert platform. The award reflects the agency's continued reliance on Cepheid's molecular diagnostic capabilities to support Defense Department medical supply chain requirements. This delivery order is part of Cepheid's broader federal contracting portfolio with the VA and Defense agencies. The company holds two significant Indefinite Delivery/Indefinite Quantity (IDIQ) vehicles with the VA's Veterans Integrated Service Networks, including a $32.8 million IDV through September 2030 for molecular diagnostic testing reagents and assays, and a $2.5 million contract focused on PCR testing for laboratory microbiology. Cepheid's federal work demonstrates the company's established position as a primary supplier of infectious disease diagnostics across the federal healthcare system, with particular emphasis on rapid detection capabilities for respiratory and infectious disease pathogens.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/1/25 |